GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Deferred Tax

AngioDynamics (FRA:UG2) Deferred Tax : €-7.1 Mil (TTM As of Feb. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

AngioDynamics's change in deferred tax for the three months ended in Feb. 2024 was €-11.2 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Feb. 2024 was €-7.1 Mil.

AngioDynamics Deferred Tax Historical Data

The historical data trend for AngioDynamics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Deferred Tax Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.37 -1.44 -3.96 -3.51 -2.13

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 -0.51 -10.47 15.12 -11.21

AngioDynamics Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.1 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Deferred Tax Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioDynamics (FRA:UG2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Deferred Tax
Comparable Companies
UTMD STXS AKYA SMTI INFU HBIO KRMD ANIK PLSE PDEX ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN
Traded in Other Exchanges
ANGO:USA UG2:Germany
Address
14 Plaza Drive, Latham, NY, USA, 12110
Website
https://www.angiodynamics.com
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines